Somatic Whole Genome Constitution Integrity Testing

Application Specifications

•Sequencing Method: Cancer Tissue WGS 200G / Normal Tissue RNA-Seq 30M / Cancer Tissue RNA-Seq 30M

•Bioinformatics Analysis: Hardware-accelerated local analysis

•Interpretation Report: Comprehensive Whole Genome Integrity Interpretation Reportㄉ

Scope of Application

1.Cancer patients seeking a comprehensive view of changes in their cancer constitution for more precise management, with the potential to incorporate personalized treatments based on the analysis, including tailored herbal constitution management.

2.Cancer patients without available targeted therapies who wish to gain a deeper understanding of their genetic constitution for precise constitution management.

3.Cancer patients interested in integrating precise herbal-based constitution adjustments alongside conventional treatment.

Testing Purpose

Through deep whole genome sequencing and dual-sample transcriptome or expression profiling, we decode all 3 billion base pairs and analyze the expression of 20,000 genes. This approach enables the analysis of various acquired genetic variations and real-time genomic function changes, reflecting shifts in constitution. By comparing the results from deep whole genome sequencing and dual transcriptome or expression profiling with key medical genomic databases from the U.S. and Europe, and applying big data analysis, we gain insights into and track real-time changes in individual acquired genetic constitution. Based on further refined analysis, precise personalized constitution management can be introduced, including tailored herbal constitution management.